SUPN

Supernus Pharmaceuticals Inc.

Price

$48.54

return (12m)

15.57%

p/e

-25.15

p/bv

2.68

DIVIDEND YIELD

0.00%

SUPN price

Supernus Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SUPN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

1.89%

3 months

-1.70%

1 year

15.57%

2 years

41.89%

5 years

101.49%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals SUPN

Valuation

P/E

-25.15

Sector -2.19

Industry 1.21

P/BV

2.68

Sector 2.22

Industry 2.11

P/Revenue (PSR)

3.33

Sector 2.01

Industry 0.78

EV/EBITDA

-80.83

Sector -17.81

Industry -25.30

EV/EBIT

-43.22

Sector -26.72

Industry -18.04

P/EBITDA

-152.19

Sector 0.36

Industry 0.18

P/EBIT

-23.06

Sector -3.34

Industry 1.26

P/Total Assets

1.94

Sector 1.23

Industry 0.86

P/Net Current Assets

8.46

Sector -27.35

Industry -12.37

P/Working Capital

7.35

Sector -4.54

Industry -49.48

EPS

-1.89

Sector -0.87

Industry -0.55

BVPS

17.78

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

88.07%

Sector 43.36%

Industry 31.53%

EBITDA Margin

-13.51%

Sector -323.65%

Industry -73.39%

EBIT Margin

-25.26%

Sector -194.57%

Industry -11.94%

Operating Margin

-6.67%

Sector -24.37%

Industry -9.87%

Net Profit Margins

-13.23%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.15

Sector 0.12

Industry 0.22

Profitability

ROE

-10.66%

Sector -33.82%

Industry -37.56%

ROA

-7.69%

Sector -29.63%

Industry -17.56%

ROIC

-1.46%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.08

Sector 1.84

Industry 1.14

Net Debt / EBITDA

12.57

Sector -1.47

Industry -31.86

Net Debt / EBIT

6.72

Sector -1.32

Industry 2.06

Net Debt / Equity

-0.36

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.00

Sector 0.14

Industry 0.51

Equity/Assets

0.72

Sector 0.42

Industry 0.25

Liabilities/Assets

0.28

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

7.45%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals SUPN

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SUPN Supernus Pharmaceuticals Inc.	$48.54	12.91%	0.00%	-25.15	2.68	-10.66%	-13.23%
LLY Eli Lilly and Compay	$1,280.34	83.05%	0.54%	39.62	31.24	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
SNY Sanofi	$45.83	-4.42%	4.04%	7.10	1.31	18.43%	13.81%
NVS Novartis AG	$160.31	31.78%	2.05%	22.57	6.87	30.41%	22.50%
TMO Thermo Fisher Scientific Inc.	$613.54	26.39%	0.30%	31.58	4.17	13.19%	15.04%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
GSK GlaxoSmithKline PLC	$52.88	41.51%	3.59%	15.15	4.28	28.24%	14.54%
CVS CVS Health Corporation	$93.65	37.68%	2.73%	25.48	1.56	6.12%	1.18%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
DHR Danaher Corporation	$211.50	0.79%	0.71%	35.81	2.73	7.61%	15.95%
HCA HCA Healthcare Inc.	$407.05	4.09%	0.74%	13.12	-27.97	-213.15%	8.77%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SUPN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Supernus Pharmaceuticals

Supernus Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

21 years

Founded: 2005

2012

Time since IPO - 14 years

563

Employees

Supernus Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $2.76 billion, with shareholders equity totaling $1.03 billion.

The company employs approximately 563 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Supernus Pharmaceuticals Inc. reported $830.44 million in revenue, generating net income of $-109.89 million.

Key financial metrics include a P/E ratio of -25.15, a price-to-book (P/B) ratio of 2.68, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SUPN.

Market cap

$2.76 billion

Net worth

$1.03 billion

$1,031,230,000.00

Assets

$1.43 billion

$1,428,110,000.00

Total Shares Outstanding

58.00 million

58,000,000

Average Daily Trading Volume

$912.08 Thousand

$912,080.00

Sector

Health

Industry

Pharmaceutical Products

SUPN

SUPN revenue and profits

Financial Results SUPN

DRAG THE FRAME TO SEE MORE DATA

SUPN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87